• A C Desbois, E Charpentier, C Chapelon, S Bergeret, N Badenco, A Redheuil, P Cacoub, and D Saadoun.
• Département de médecine interne et immunologie clinique, groupe hospitalier Pitié-Salpêtrière, Sorbonne universités, AP-HP, 75013 Paris, France; Inserm, UMR S 959, Immunology-Immunopathology-Immunotherapy (I3), centre national de références maladies auto-immunes et systémiques rares, centre national de références maladies auto inflammatoires rares et Amylose inflammatoire, 75005 Paris, France. Electronic address: anneclaire.desbois@aphp.fr.
• Rev Med Interne. 2022 Apr 1; 43 (4): 212-224.

AbstractSarcoidosis is a systemic granulomatous disease characterized by pulmonary involvement in most patients and more rarely by extrapulmonary involvement such as ocular, skin, salivary, lymph nodes and joints damages. Neurological and cardiac involvements are uncommon but are associated with increased morbidity and mortality. Cardiac sarcoidosis affects 5 to 20% of patients depending on the studies and autopsy studies even report cardiac involvement in 25% of sarcoidosis patients. This review aims to summarise main data on the diagnostic value of the different imaging techniques in cardiac sarcoidosis and to also detail the management of these patients who require a multidisciplinary approach.Copyright © 2021. Published by Elsevier Masson SAS.

20 keywords...

hide…